Metronidazole Extended-Release Tablets USP 600 Mg – Extended-Release Antiprotozoal & Anaerobic Coverage.
OCTIMIN 600 ER: The Composition of Metronidazole 600 ER is a nitroimidazole-class antimicrobial agent with both antiprotozoal and antibacterial effects. It disrupts DNA synthesis in anaerobic organisms and protozoa, leading to cell death. The sustained-release (SR) formulation ensures prolonged activity, reducing the need for frequent dosing, particularly beneficial in chronic infections such as amoebiasis or bacterial vaginosis.
Recommended by Specialists:
✅General Physicians: Treating the disease associated with anaerobic bacterial and protozoal infections is preferred.
✅Gastroenterologists –Treating the diseases associated with amoebiasis, giardiasis, Clostridium difficile infections, and other intestinal infections is preferred.
✅Neurologists – It is preferred to treat the disease associated with brain abscesses caused by anaerobic organisms.
Key Benefits of Metronidazole Extended Release Tablets USP 600 Mg – OCTIMIN 600 ER:
✅Sustained-Release for Better Compliance : Once or twice daily dosing maintains consistent therapeutic levels, enhancing patient adherence in chronic infections.
✅Potent Anaerobic & Antiprotozoal Action : Effective against Entamoeba histolytica, Giardia lamblia, Trichomonas vaginalis, and anaerobic bacteria like Bacteroides.
✅Reduces Recurrence & Resistance Risk : Extended exposure reduces bacterial load and helps prevent treatment failure or resistance.
INDICATIONS:
✅Trichomoniasis
✅Anaerobic Bacterial Infections
✅Bacterial Vaginosis
✅Pelvic Inflammatory Disease
✅Surgical Prophylaxis in Colorectal Procedures